Background: Endoleakage is a fairly common problem after endovascular repair of abdominal aortic aneurysm and may prevent successful exclusion of the aneurysm. The consequences of endoleakage in terms of pressure in the aneurysmal sac are not exactly known. Moreover, the diagnosis of endoleakage is a problem because visualization of endoleaks can be difficult.
Endovascular therapy has become accepted for selected abdominal aneurysms. 1 The objective of this therapy is to exclude the aneurysm from the circulation and to reduce pressure on the aneurysmal wall to prevent rupture. Endoleakage is associated with endoluminal vascular grafts. It is defined by the persistence of blood flow outside the lumen of the endoluminal graft but within the aneurysmal sac or adjacent vascular segment being treated with the graft. 2 Endoleakage indicates failure completely to exclude the aneurysm from the circulation and may result in rupture. 3, 4 The reported incidence of endoleakage varies widely (0% to 44%) 2 depending on the device being used, patient selection, implantation technique, and the method of evaluation.
The diagnosis of endoleakage relies exclusively on imaging. This may present a problem, however, because visualization of the endoleak can be difficult. It is not known how much flow through the endoleak or how much contrast agent is required to visualize an endoleak. That some aneurysms continue to enlarge after endovascular treatment without a confirmed endoleak suggests the leaks are not being visualized. Also not known are the consequences of endoleakage in terms of pressure in the aneurysmal sac. There is consensus that large endoleaks should be repaired, but there is no consensus about the consequences of small endoleaks. To evaluate the effect of endoleakage on the pressure in the aneurysmal sac we quantified diameters of endoleaks in a tube-graft exclusion model of aneurysms in an artificial circulation. We examined imaging with digital subtraction angiography (DSA), computed tomographic angiography (CTA), and delayed CTA and the effects on pressure in the aneurysmal sac.
METHODS
In vitro model. The experiments were performed in an in vitro circulation. The model consisted of an artificial heart driven by an artificial pneumatic heart driver, a tubing system, peripheral resistance, and a collecting system [5] [6] [7] [8] (Fig. 1) . The artificial heart consisted of two valves and one 70 ml chamber. The pneumatic heart driver could be varied in frequency, diastolic suction pressure, systolic driving pressure, and proportion of time between systole and diastole. Rubber tubing was used proximal to the aortic aneurysm to make the system more compliant. Silastic polymeric silicone tubing was used distal to the segment with the aneurysm. Peripheral resistance was produced and adjusted with a cuff around a segment of rubber tubing to mimic the human peripheral circulation.
An aneurysm was made in the ex vivo circulation. The aneurysm was constructed of rubber tubing and Fig. 1 . Schematic of ex vivo circulation. The model is driven by an artificial heart driver (A) and consists of an artificial heart (B), tubing system, aneurysm model (C) with simulated lumbar artery (D) and working port (E), blood pressure cuff (F) and open reservoir (G). Two pressure catheters were inserted through side ports of the tubing (H) and the aneurysm (I), and one flow transducer (J) was used.
was about 25 cm long. Aneurysmal diameter was 7 cm in the middle section and 2 cm at each end. In the wide middle segment, three small side ports were constructed for connection of branches (simulated lumbar arteries) and introduction of a pressure measurement catheter. One larger side port also was available for introduction of varying sizes of catheters to produce the endoleaks. The lumbar side branches had a diameter of 2 mm and could be closed or open without outflow resistance.
An 18 mm knitted polyethylene tube graft (Hemashield; Meadox Medical, Oakland, N.J.) was glued to disposable tube connectors and fixed in the aneurysmal neck at the proximal and distal ends. To avoid leakage through the prosthesis in the absence of a normal clotting mechanism, the prosthesis was preclotted five times in 15 minutes alternately in 1 IE/ml bovine thrombin (Fibriquik; Organon Teknika, Durham, N.C.) and in fresh frozen plasma. Thus the prosthesis was made impervious to the perfusate. The perfusate consisted of a starch solution with a plasmalike viscosity. It allowed imaging of flow by means of duplex ultrasonography because of reflection of the ultrasound by the fine starch particles.
A variable endoleak port was made in the tube graft (Fig. 2) . Through a valve in a 10-French (3.33 mm) sheath sutured and glued into the prosthesis, segments of sheaths and catheters were introduced. To avoid differences in measurements because of resistance, all segments had the same length, 2 cm. By varying the diameter of the segments, we varied Model characteristics. In the system we varied pressure from 110/50 mmHg to 200/100 mmHg by changing diastolic suction pressure and systolic driving pressure to the artificial heart and by changing peripheral resistance. The stroke volume of the artificial heart was manipulated to allow flow variation through the aneurysm or graft from 1.05 to 2.1 L/min. Duplex ultrasonographic examination of the flow in the aortic segment revealed a triphasic flow pattern with a peak systolic velocity of 0.95 m/sec. The pressure curve in this segment was identical to that of an animal or person. In this study, duplex and flow measurements were used regularly to check whether the experimental conditions were constant and physiologic.
The experiments. The pulsatile flow model, including the aneurysm, prosthesis, and endoleak model, was evaluated by means of DSA (Integris V3000; Philips Medical Systems, Best, The Netherlands) and CTA (Philips CT SR7000; Philips Medical Systems, Best, The Netherlands). On the basis of pilot experiments, we decided to use a 1.231-French (0.410 mm) inner lumen catheter and 3-French (1 mm) and 7-French (2.33 mm) sheaths for endoleaks.
The experiments were performed in the absence of endoleaks (controls) and in the presence of small and large endoleaks. In each experiment pressure and flow in the prosthesis and pressure in the aneurysmal sac were recorded. At the start of each experiment the pressure in the aneurysmal sac was 0 mm Hg with an intact pulsatile circulation and a flow of 1.8 L/min.
Both CTA and delayed CTA were performed with 5 mm collimation width, 1:1 pitch, and 80 ml of contrast material (Isopaque cysto; Byk, Milan, Italy). For CTA, a 2.0 ml/sec infusion rate was used with a 5-second scan delay. For delayed CTA 40 ml of contrast material was infused during the first 20 seconds (2.0 ml/sec), followed by a 35-second delay and infusion of 40 ml of contrast material in 27 seconds (1.5 ml/sec). Scan delay was 1 minute.
DSA was performed with on-hand bolus administration of 20 ml of contrast material (Isopaque cysto). DSA was repeated with 20 cm Lucite acrylic plates. The plates were added to study whether increased scatter-radiation levels produced by the plates would result in decreased sensitivity to visualization of endoleaks. The thickness of the Lucite acrylic plates was such that scatter values were comparable with those of an average-sized person. 9, 10 Because small endoleaks might be visualized only in the presence of an outflow tract, we repeated the experiments with an open lumbar artery if no endoleak was visualized in the experiments without an outflow tract. After each experiment, the aneurysmal sac content was replaced with fresh, contrast-free starch solution. Because thrombus formation after exclusion of an aneurysm by a stent graft can influence pressure measurements and visualization, all tests were repeated while the aneurysmal sac was filled with thrombus made with thrombin and fresh frozen plasma. All tests were performed twice and in case of discrepancy a third time.
RESULTS
Pressure measurements. In the absence of an endoleak, pressure was 0 mm Hg within the aneurysmal sac in all instances. After introduction of an endoleak, the pressure within the aneurysmal sac increased until diastolic pressure in both the aneurysmal sac and the lumen of the prosthesis was similar. However, the form of the pressure wave in the sac was different from that in the prosthesis. The pressure curve in the aneurysmal sac was damped compared with the systemic pressure curve with a similar diastolic pressure but a lower systolic pressure (Fig. 3) .
All endoleaks eventually resulted in the same pressure curve in the aneurysmal sac, producing diastolic pressure levels identical to those in the systemic circulation. However, the time needed for building of pressure varied in inverse proportion to the size of the endoleaks. In the presence of a 1.231-French (0.410 mm) endoleak the pressure in the aneurysmal sac equilibrated after 87 minutes at 70/53 mm Hg with a pressure in the prosthesis of 149/56 mm Hg. With the 3-French (1 mm) and 7-French (2.33 mm) endoleaks the equilibration times were 28 and 8 minutes, respectively (Table I) . The pressures and equilibration times were similar in the presence and absence of thrombus mass in the aneurysmal sac (Table II) .
Angiography. Without an endoleak present, accumulation of contrast material was never visualized in the aneurysmal sac with DSA, with or without thrombus mass inside the aneurysmal sac (Tables III and IV) . DSA showed contrast leakage with 3-French (1mm) and 7-French (2.33 mm) endoleaks present. The 1.231-French (0.410 mm) endoleak was visualized on DSA, but not if Lucite acrylic plates were situated beneath the aneurysm. However, the endoleak was again visualized as soon as a 'lumbar artery' was opened.
In the presence of thrombus within the aneurysmal sac, the 3-French (1mm) and 7-French (2.33 mm) endoleaks could always be visualized by DSA. The 1.231-French (0.410 mm) catheter endoleak could not be seen, neither with nor without a Lucite acrylic plate barrier. However, after 15 minutes contrast accumulation within the aneurysmal sac could be seen on fluoroscopy.
Computed tomography. CTA and delayed CTA of the aneurysm model without an endoleak showed never contrast accumulation in the aneurys- aneurysmal sac. With the delayed CTA protocol, all endoleaks were visualized, either with or without thrombus mass inside the aneurysmal sac.
DISCUSSION
Failure to exclude the aneurysm from the circulation is most clearly demonstrated with an increase of the diameter of the aneurysm. This is caused by an endoleak. Such an endoleak most often originates from the proximal or distal end of the stent graft. 11 However, aneurysm enlargement infrequently is associated with endoleakage combined with an open side branch 12 or even without visualization of an endoleak. Nevertheless, such a sealed endoleak can be associated with aneurysm shrinkage. 13 However, in the time before reduction of aneurysmal diameter can occur, the patient may still be at risk for rupture of the aneurysm.
One of the main findings of this study was that even a small endoleak causes considerable pressure in the aneurysmal sac. The level of the pressure is independent of the size of the endoleak. However, equilibration time is related to the size of the endoleak. The pressure level and wave form in the aneurysmal sac are different from those in the systemic circulation. Systolic pressure is considerably reduced, but diastolic pressure is similar to that in the systemic circulation. Consequently mean pressure level is reduced. Only in the case of the 1.231-French (0.410 mm) endoleak combined with thrombus in the aneurysmal sac, was diastolic pressure higher in the sac than in the systemic circulation. Thrombus on the catheter tip may have caused a valve phenomenon, which could explain this difference in diastolic pressure.
Even a small endoleak may result in clinically significant pressure in the aneurysmal sac. Consequently risk for rupture has probably not been eliminated. Clinical reports confirm that persistent endoleakage may result in rupture of the aneurysm despite endovascular stent graft placement. 3, 4 Whether the risk for rupture will be reduced because of either a decreased pulse or mean pressure in the aneurysmal sac compared with the situation before stent-graft placement has yet to be established.
Unlike the situation in other studies, the pressure in the aneurysmal sac remained zero in the absence of an endoleak. With an animal model of exclusion of a polytetrafluoroethylene (PTFE) aneurysm of the abdominal aorta, Faries et al. 14 and Sanchez et al. 15 found a damped pulsatile pressure curve in the aneurysmal sac compared with systemic pressure. Because of the small size of the aneurysm and the stiffness of the aneurysmal wall, the change in diameter of the prosthesis during the heart cycle may result in a pressure elevation in the aneurysmal sac sooner than in our study with an ex vivo model. After insertion of a high-porosity stent graft, Sanchez et al. found a marked decrease in reduction of intraaneurysmal pressure compared with the results with a PTFE stent graft. In our study, the influence of the porosity of the fabric on intraaneurysmal pressure was excluded by means of preclotting of the prosthesis.
The clinical observation of a damped pulsatile pressure by Chuter et al. 16 may have been caused by a nonvisualized perigraft endoleak or permeability of the polyethylene (Dacron) prosthesis soon after stent graft placement. On the contrary, our test results were nonphysiologic because of ex vivo circumstances, such as the lack of surrounding soft tissue, absence of intraabdominal pressure, and difference in compliance between human aneurysmal wall and an artificial aneurysm. Another important finding in our study was that not every endoleak is visualized by means of CTA and DSA. This was the case despite use of a high-quality, dedicated angiography system and absence of the attenuation of x-rays by soft tissues.
The increased scatter radiation in patients deteriorates image quality, which results in lower sensitivity for endoleaks. This was demonstrated in our experiments when we added Lucite acrylic plates with a thickness such that a scatter level equivalent to that with patients was obtained. It is reasonable to expect that in less favorable circumstances, such as an operating theater with a portable image intensifier, visualization of endoleaks is much more difficult. Therefore absence of an endoleak at DSA and CTA does not exclude pressurization of the aneurysmal sac.
The strongest argument that management of an aneurysm is successful is reduction of the diameter of the aneurysmal sac during follow-up examinations. Unfortunately, shrinkage of the aneurysm after stent graft placement takes several months to become visible, 13 which means that a patient with an endoleak that is not visualized can be at risk in this time interval. Thus without a decrease in aneurysm size, an endoleak is not absolutely excluded. Even with shrinkage of the aneurysm, endoleak is not excluded but rupture is.
Compared with CTA, improvement of visualization of endoleaks can be established with delayed CTA. Other authors have suggested this, but reports in which this suggestion has been substantiated are not yet available.
Fresh thrombus mass in the aneurysmal sac does not change pressure measurements compared with the presence of fluids in the aneurysmal sac. The finding that thrombus conducts pressure is in agreement with reports mentioning rupture of surgically thrombosed aortic aneurysms 17 and has also been reported in experimental models. 14, 15 In vivo, several endoleaks may seal spontaneously, but it is not known how large the surface of a thrombosed endoleak should be to transduce pressure causing clinically significant elevated pressure in the aneurysmal sac. This will need to be investigated in future experiments.
As "small" endoleaks could cause identical pressure in the aneurysmal sac as larger endoleaks, we believe that the follow up after stent graft placement for aortic aneurysms must not focus on visualization exclusively, but also on the effects of endoleaks in terms of aneurysm wall motion changes and pressure measurements inside the aneurysmal sac. A possible JOURNAL OF VASCULAR SURGERY August 1998 alternative is the measuring of the aneurysm pulsatile wall motion, which may be reduced after endovascular exclusion of the aneurysm. Endoleakage, independent of its origin, seems to be associated with less decrease in pulsatile wall motion of the aneurysm. 18 The clinical usefulness of this test has to be confirmed.
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Development of techniques of pressure measurement in the out-patient situation will be necessary. This system could consist of micro pressure sensors, which can be inserted during the initial procedure between the aneurysmal wall and the stent-graft. Wireless pressure readouts must be obtained during follow up. At the moment, our group is working on such a project. If such a device can be developed, intensive and long lasting follow up by CT and duplex ultrasonography might no longer be needed.
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